Consistent with this concept, our results indicate that TPH104 not only killed MDA-MB-231 cells via a non-apoptotic pathway but also caused ICD, accompanied by the release of the pro-inflammatory mediator TNFα, to increase the adaptive immune response against cancer cells. The gene discussed is TNF; the disease is cancer.